RaQualia Pharma Inc. (TYO:4579)

Japan flag Japan · Delayed Price · Currency is JPY
501.00
-13.00 (-2.53%)
Jun 3, 2026, 3:30 PM JST
Market Cap13.38B +31.3%
Revenue (ttm)3.81B +11.4%
Net Income53.22M
EPS2.14
Shares Out 26.03M
PE Ratio240.20
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume472,100
Open524.00
Previous Close514.00
Day's Range497.00 - 530.00
52-Week Range484.00 - 1,465.00
Beta0.87
Analystsn/a
Price Targetn/a
Earnings DateMay 15, 2026

About RaQualia Pharma

RaQualia Pharma Inc. engages in the research and development of pharmaceutical compounds worldwide. The company human products portfolio includes tegoprazan for gastroesophageal reflux disease; and grapiprant for cancer and pain management; RQ-00000008 for the treatment of osteoarthritis autoimmune disorders; RQ-00000010 to treat gastroparesis. It also provides veterinary products, such as capromorelin to treat anorexia in dogs and weight management in cats; grapiprant for osteoarthritis in dogs; RQ-00000008 to treat osteoarthritis and others; ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 85
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4579
Full Company Profile

Financial Performance

Financial Statements